Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Randomized, Controlled Trial

PURPOSE. To evaluate the effects of epoetin alfa on patient-reported outcomes (PROs) in patients with breast cancer receiving myelotoxic chemotherapy. MATERIALS AND METHODS. Women with hemoglobin concentrations ≤12.0 g/dl and an Eastern Cooperative Oncology Group performance status (ECOG PS) score o...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Pronzato, Paolo, Cortesi, Enrico, van der Rijt, Carin C., Bols, Alain, Moreno-Nogueira, José A., de Oliveira, Carlos Freire, Barrett-Lee, Peter, Ostler, Peter J., Rosso, Ricardo
Format: Artigo
Jezik:Inglês
Izdano: AlphaMed Press 2010
Teme:
Academia–Pharma Intersect
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228044/
https://ncbi.nlm.nih.gov/pubmed/20798194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0279
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items